Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Orion Oyj    ORNBV   FI0009014377

ORION OYJ

(ORNBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Orion Oyj : Finnish drugmaker Orion's second-quarter profit, sales beat forecasts

07/17/2020 | 05:26am EST

Finnish drugmaker Orion on Friday reported better-than-expected April-June profits and sales, boosted by a milestone payments for its prostate cancer drug.

Orion's operating profit rose 85% from a year earlier to 96.4 million euros ($110 million) on sales up 16% to 292.5 million euros, both well ahead of analysts expectations Refinitiv Eikon data showed.

Last week Orion said it expects operating profit this year to be higher than in 2019, after previously forecasting a flat outcome.

($1 = 0.8763 euros)

(Reporting by Tarmo Virki in Tallinn; editing by Jason Neely)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ORION HOLDINGS CORP. 0.38% 13150 End-of-day quote.-0.38%
ORION OYJ -0.28% 38.65 Delayed Quote.3.28%
All news about ORION OYJ
01/20ORION OYJ : publishes Financial Statement Release for 2020 on Tuesday 9 February..
AQ
01/18ORION OYJ : Animal Health and Vetoquinol expand collaboration – Vetoquinol..
AQ
01/12ORION OYJ : Recommendation by the Nomination Committee concerning the Board of D..
AQ
2020NUVO PHARMACEUTICALS INC : . - Miravo Healthcare Ireland Enters into Suvexx Lice..
AQ
2020ORION OYJ : 8,242 Orion Corporation A shares converted into B shares
AQ
2020ORION OYJ : invests EUR 17 million in its production plants in Turku
PU
2020ORION OYJ : Prosecutor pressed charges against a member of Orion's Board of Dire..
PU
2020ORION OYJ : Prosecutor pressed charges against a member of Orion's Board of Dire..
AQ
2020Prosecutor pressed charges against a member of Orion's Board of Directors for..
GL
2020ORION OYJ : Composition of the Nomination Committee of Orion Corporation
PU
More news
Financials
Sales 2020 1 087 M 1 323 M 1 323 M
Net income 2020 234 M 285 M 285 M
Net cash 2020 131 M 160 M 160 M
P/E ratio 2020 23,3x
Yield 2020 3,84%
Capitalization 5 429 M 6 593 M 6 608 M
EV / Sales 2020 4,87x
EV / Sales 2021 5,00x
Nbr of Employees 3 320
Free-Float 86,5%
Chart ORION OYJ
Duration : Period :
Orion Oyj Technical Analysis Chart | ORNBV | FI0009014377 | MarketScreener
Technical analysis trends ORION OYJ
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 33,78 €
Last Close Price 38,65 €
Spread / Highest target 8,67%
Spread / Average Target -12,6%
Spread / Lowest Target -27,6%
EPS Revisions
Managers and Directors
NameTitle
Timo Antero Lappalainen President & Chief Executive Officer
Satu Maarit Ahomäki Senior Vice President-Commercial Operations
Jari Ilmari Karlson Chief Financial Officer & SVP-Animal Health
Sinikka Markkula Chief Information Officer
Minna Ruotsalainen Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ORION OYJ3.28%6 588
JOHNSON & JOHNSON2.76%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.90%202 881